Taurine and its potential therapeutic application;Tauryna i jej potencjalne wykorzystanie w terapii

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 62, Issue , 2008, Pages 75-86

  Szymański, Konrad ^a   Winiarska, Katarzyna ^a  

^a UNIVERSITY OF WARSAW   (Poland)

Author keywords

Antioxidant; Metabolism; Taurine; Therapy

Indexed keywords

TAURINE;

ANIMAL; CARDIOMYOPATHY; HUMAN; HYPERCHOLESTEROLEMIA; PHYSIOLOGY; REVIEW;

ANIMALS; CARDIOMYOPATHIES; HUMANS; HYPERCHOLESTEROLEMIA; TAURINE;

EID: 41049116346     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: None     Document Type: Article

References (150)

1. Abdih H., Kelly C.J., Bouchier-Hayes D., Barry M., Kearns S.: Taurine prevents interleukin-2-induced acute lung injury in rats. Eur. Surg. Res., 2000; 32: 347-352
2. Aksnes T.A., Reims H.M., Kjeldsen S.E., Mancia G.: Antihypertensive treatment and new-onset diabetes mellitus. Curr. Hypertens. Rep., 2005; 7: 298-303
3. Altshuler D., Lo Turco J.J., Rush J., Cepko C.: Taurine promotes the differentiation of a vertebrate retinal cell type in vitro. Development, 1993; 119: 1317-1328
4. Backus R.C., Rogers Q.R., Rosenquist G.L., Calam J., Morris J.G.: Diets causing taurine depletion in cats substantially elevated postprandial plasma cholecystokinin concentration. J. Nutr., 1995; 125: 2650-2657
5. Bagley P.J, Stipanuk M.H.: The activities of rat hepatic cysteine dioxygenase and cysteinesulfinate decarboxylase are regulated in a reciprocal manner in response to dietary casein level. J. Nutr., 1994; 124: 2410-2421
6. Bagley P.J., Stipanuk M.H.: Rats fed a low protein diet supplemented with sulfur amino acids have increased cysteine dioxygenase activity and increased taurine production in hepatocytes. J. Nutr., 1995; 125: 933-940
7. Barua M., Liu Y., Quinn M.R.: Taurine chloramine inhibits inducible nitric oxide synthase and TNF-A gene expression in activated alveolar macrophages: Decreased NF-κB activation and IkB kinase activity. J. Immunol., 2001; 167: 2275-2281
8. Bedrosian I., Sofia R.D., Wolf S.M., Dinarello C.A.: Taurolidine, an analogue of the amino acid taurine, suppresses interleukin 1 and tumor necrosis factor synthesis in human peripheral blood mononuclear cells. Cytokine, 1991; 3: 568-575
9. Beetsch J.W., Olson J.E.: Taurine synthesis and cysteine metabolism in cultured rat astrocytes: Effects of hyperosmotic exposure. Am. J. Physiol., 1998; 274: C866-C874
10. Bella D.L., Hahn C., Stipanuk M.H.: Effects of nonsulfur and sulfur amino acids on the regulation of hepatic enzymes of cysteine metabolism. Am. J. Physiol., 1999; 277: E144-E153
11. Bella D.L., Hirschberger L.L., Hosokawa Y., Stipanuk M.H.: Mechanisms involved in the regulation of key enzymes of cysteine metabolism in rat liver in vivo. Am. J. Physiol., 1999; 276: 326-335
12. Bella D.L., Hirschberger L.L., Kwon Y.H., Stipanuk M.H.: Cysteine metabolism in periportal and perivenous hepatocytes: Perivenous cells have greater capacity for glutathione production and taurine synthesis but not for cysteine catabolism. Amino Acids, 2002, 23: 454-458
13. Bella D.L., Stipanuk M.H.: Effects of protein, methionine, or chloride on acid-base balance and on cysteine catabolism. Am. J. Physiol., 1995; 269: E910-E917
14. Beneck D., Suhrland M.J., Dicker R., Greco M.A., Wolman S.R.: Deletion of the short arm of chromosome 3: A case report with necropsy findings. J. Med. Genet., 1984; 21: 307-310
15. Bitoun M., Levillain O., Tappaz M.: Gene expression of the taurine transporter and taurine biosynthetic enzymes in rat kidney after antidiuresis and salt loading. Pflugers Arch., 2001; 442: 87-95
16. Bitoun M., Tappaz M.: Gene expression of the transporters and biosynthetic enzymes of the osmolytes in astrocyte primary cultures exposed to hyperosmotic conditions. Glia., 2000; 32: 165-176
17. Bitoun M., Tappaz M.: Gene expression of taurine transporter and taurine biosynthetic enzymes in brain of rats with acute or chronic hyperosmotic plasma: A comparative study with gene expression of myo-inositol transporter, betaine transporter and sorbitol biosynthetic enzyme. Brain Res. Mol. Brain Res., 2000; 77: 10-18
18. Bitoun M., Tappaz M.: Taurine down-regulates basal and osmolarity-induced gene expression of its transporter, but not the gene expression of its biosynthetic enzymes, in astrocyte primary cultures. J. Neurochem., 2000; 75: 919-924
19. Bosch J., Lonn E., Pogue J., Arnold J.M., Dagenais G.R., Yusuf S.: Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension. Circulation, 2005; 112: 1339-1346
20. Brandsch M., Miyamoto Y., Ganapathy V., Leibach F.H.: Regulation of taurine transport in human colon carcinoma cell lines (HT-29 and Caco-2) by protein kinase C. Am. J. Physiol., 1993; 264: G939-G946
21. BRENDA: The Comprehensive Enzyme Information System. http://www.brenda-enzymes.info (05.02.2008)
22. Bridges C.C., Ola M.S., Prasad P.D., El-Sherbeny A., Ganapathy V., Smith S.B.: Regulation of taurine transporter expression by NO in cultured human retinal pigment epithelial cells. Am. J. Physiol. Cell. Physiol., 2001; 281: C1825-C1836
23. Bustamante J., Lobo M.V., Alonso F.J., Mukala N.T., Ginè E., Solis J.M., Tamarit-Rodriguez J., Martin del Río R.: An osmotic-sensitive taurine pool is localized in rat pancreatic islet cells containing glucagon and somatostatin. Am. J. Physiol. Endocrinol. Metab., 2001; 281: E1275-E1285
24. Chan P., Wong K.L., Liu I.M., Tzeng T.F., Yang T.L., Cheng J.T.: Antihyperglycemic action of angiotensin II receptor antagonist, valsartan, in streptozotocin-induced diabetic rats. J. Hypertens., 2003; 21: 761-769
25. Chesney R.W., Gusowski N., Dabbagh S.: Renal cortex taurine content regulates renal adaptive response to altered dietary intake of sulfur amino acids. J. Clin. Invest., 1985; 76: 2213-2221
26. Chiarla C., Giovannini I., Siegel J.H., Boldrini G., Castagneto M.: The relationship between plasma taurine and other amino acid levels in human sepsis. J. Nutr., 2000; 130: 2222-2227
27. Coloso R.M., Stipanuk M.H.: Metabolism of cyst(e)ine in rat enterocytes. J. Nutr., 1989; 119: 1914-1924
28. Cubillos S., Lima L.: Differential taurine effect on outgrowth from goldfish retinal ganglion cells after crush or axotomy of the optic nerve. International Satellite Taurine Symposium, International Society for Neurochemistry, Abst. 1997; 29: 16
29. Da Costa M.L., Redmond H.P., Bouchier-Hayes D.J.: Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery. J. Surg. Res., 2001; 101: 111-119
30. De Luca A., Pierno S, Liantonio A., Cetrone M., Camerino C., Fraysse B., Mirabella M., Servidei S., Rüegg U.T., Conte Camerino D.: Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1. J. Pharmacol. Exp. Ther., 2003; 304: 453-463
31. De Luca A., Pierno S., Tricarico D., Desaphy J.F., Liantonio A., Barbieri M., Camerino C., Montanari L., Camerino D.C.: Taurine and skeletal muscle ion channels. Adv. Exp. Med. Biol., 2000; 483: 45-56
32. Della Corte L., Crichton R.R., Duburs G., Nolan K., Tipton K.F., Tirzitis G., Ward R.J.: The use of taurine analogues to investigate taurine functions and their potential therapeutic applications. Amino Acids, 2002; 23: 367-379
33. Di Leo M.A., Ghirlanda G., Gentiloni Silveri N., Giardina B., Franconi F., Santini S.A.: Potential therapeutic effect of antioxidants in experimental diabetic retina: A comparison between chronic taurine and vitamin E plus selenium supplementations. Free Radic. Res., 2003; 37: 323-330
34. Di Leo M.A., Santini S.A., Cercone S., Lepore D., Gentiloni Silveri N., Caputo S., Greco A.V., Giardina B., Franconi F., Ghirlanda G.: Chronic taurine supplementation ameliorates oxidative stress and Na+/K+ ATPase impairment in the retina of diabetic rats. Amino Acids, 2002; 23: 401-406
35. Domagała J.: Tauryna-cenny składnik mleka koziego. Medycyna Wet., 2003; 59: 571-574
36. Earm Y.E., Ho W.K., SO I., Leem C.H., Han J.: Effect of taurine on theactivation of background current in cardiac myocytes of the rabbit. W: Ionic channels and effect of taurine on the heart, red.: Noble D., Earm Y.E. Kluwer Academic Publishers, Boston, 1993, 119-138
37. Egan B.M., Abdih H., Kelly C.J., Condron C. Bouchier-Hayes D.J.: Effect of intravenous taurine on endotoxin-induced acute lung injury in sheep. Eur. J. Surg., 2001; 167: 575-580
38. Englert R.P., Shacter E.: Distinct modes of cell death induced by different reactive oxygen species: amino acyl chloramines mediate hypochlorous acid-induced apoptosis. J. Biol. Chem., 2002; 277: 20518-20526
39. Ensunsa J.L., Hirschberger L.L., Stipanuk M.H.: Catabolism of cysteine, cystine, cysteinesulfinate, and OTC by isolated perfused rat hindquarter. Am. J. Physiol., 1993; 264: E782-E789
40. Ferraris J.D., Williams C.K., Ohtaka A., Garcia-Perez A.: Functional consensus for mammalian osmotic response elements. Am. J. Physiol., 1999; 276: C667-C673
41. Fletcher E.L., Kalloniatis M.: Neurochemical development of the degenerating rat retina. J. Comp. Neurol., 1997; 388: 1-22
42. Foos T.M., Wu J.Y.: The role of taurine in the central nervous system and the modulation of intracellular calcium homeostasis. Neurochem. Res., 2002; 27: 21-26
43. Franconi F., Loizzo A., Ghirlanda G., Seghieri G.: Taurine supplementation and diabetes mellitus. Curr. Opin. Clin. Nutr. Metab. Care., 2006; 9: 32-36
44. Friedman A.L., Albright P.W., Gusowski N., Padilla M., Chesney R.W.: Renal adaptation to alteration in dietary amino acid intake. Am. J. Physiol., 1983; 245: F159-F166
45. Fukuda K., Hirai Y., Yoshida H., Nakajima T., Usui T.: Free-amino acid content of lymphocytes and granulocytes compared. Clin. Chem., 1982; 28: 1758-1761
46. Ganapathy V., Ramamoorthy J.D., Del Monte M.A., Leibach F.H., Ramamoorthy S.: Cyclic AMP-dependent up-regulation of the taurine transporter in a human retinal pigment epithelial cell line. Curr. Eye Res., 1995; 14: 843-850
47. Gandhi V.M., Mulky M.J.: Some pharmacological studies on taurine. Ind. J. Pharmac., 1990; 22: 128-132
48. GenBank: Genetic Sequence Data Bank of National Center for Biotechnology Information. http://www.ncbi.nlm.nih.gov/Genbank/index.html (05.02.2008)
49. Godley L.A., Kopp J.B., Eckhaus M., Paglino J.J., Owens J., Varmus H.E.: Wild-type p53 transgenic mice exhibit altered differentiation of the ureteric bud and possess small kidneys. Genes Dev., 1996; 10: 836-850
50. Han X., Budreau A.M, Chesney R.W.: The taurine transporter gene and its role in renal development. Amino Acids, 2000; 19: 499-507
51. Han X., Budreau A.M., Chesney R.W.: Adaptive regulation of MDCK cell taurine transporter (pNCT) mRNA: Transcription of pNCT gene is regulated by external taurine concentration. Biochim. Biophys. Acta, 1997, 1351: 296-304
52. Han X., Budreau A.M., Chesney R.W.: Ser-322 is a critical site for PKC regulation of the MDCK cell taurine transporter (pNCT). J. Am. Soc. Nephrol., 1999; 10: 1874-1879
53. Han X., Budreau A.M., Chesney R.W.: Cloning and characterization of the promoter region of the rat taurine transporter (TauT) gene. Adv. Exp. Med. Biol., 2000; 483: 97-108
54. Han X., Budreau A.M., Chesney R.W.: Identification of promoter elements involved in adaptive regulation of the taurine transporter gene: role of cytosolic Ca2+ signaling. Adv. Exp. Med. Biol., 2000; 483: 535-544
55. Han X., Patters A.B., Chesney R.W.: Transcriptional repression of taurine transporter gene (TauT) by p53 in renal cells. J. Biol. Chem., 2002; 277: 39266-39273
56. Hansen S.H.: The role of taurine in diabetes mellitus and development of diabetic complications. Diabetes Metab. Res. Rev., 2001; 17: 330-346
57. Henriksen E.J., Jacob S., Kinnick T.R., Teachey M.K., Krekler M.: Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats. Hypertension, 2001; 38: 884-890
58. Hirschberger L.L., Daval S., Stover P.J., Stipanuk M.H.: Murine cysteine dioxygenase gene: Structural organization, tissue-specific expression and promoter identification. Gene, 2001; 277: 153-161
59. Huxtable R.J.: Taurine in the central nervous system and the mammalian actions of taurine. Prog. Neurobiol., 1989; 32: 471-533
60. Huxtable R.J.: The physiological actions of taurine. Physiol. Rev., 1992; 72: 101-163
61. Ishizuka K., Miyamoto Y., Satsu H., Sato R., Shimizu M.: Characteristics of lysophosphatidylcholine in its inhibition of taurine uptake by human intestinal Caco-2 cells. Biosci. Biotechnol. Biochem., 2002; 66: 730-736
62. Jerkins A.A., Bobroff L.E., Steele R.D.: Hepatic cysteine sulfinic acid decarboxylase activity in rats fed various levels of dietary casein. J. Nutr., 1989; 119: 1593-1597
63. Jerkins A.A., Jones D.D., Kohlhepp E.A.: Cysteine sulfinic acid decarboxylase mRNA abundance decreases in rats fed a high-protein diet. J. Nutr., 1998; 128: 1890-1895
64. Jerkins A.A., Steele R.D.: Cysteine sulfinic acid decarboxylase activity in response to thyroid hormone administration in rats. Arch. Biochem. Biophys., 1991; 286: 428-432
65. Jerkins A.A., Steele R.D.: Dietary sulfur amino acid modulation of cysteine sulfinic acid decarboxylase. Am. J. Physiol., 1991; 261: E551-E555
66. Jerkins A.A., Steele R.D.: Quantification of cysteine sulfinic acid decarboxylase in male and female rats: Effect of adrenalectomy and methionine. Arch. Biochem. Biophys., 1992; 294: 534-538
67. Jhiang S.M., Fithian L., Smanik P., McGill J., Tong Q., Mazzaferri E.L.: Cloning of the human taurine transporter and characterization of taurine uptake in thyroid cells. FEBS Lett., 1993; 318: 139-144
68. Jian X., Hidaka H. Schmidt J.T.: Kinase requeriment for retinal growth cone motility. J. Neurobiol., 1994; 25: 1310-1328
69. Jones D.P., Miller L.A., Chesney R.W.: The relative roles of external taurine concentration and medium osmolality in the regulation of taurine transport in LLC-PK1 and MDCK cells. Pediatr. Res., 1995; 37: 227-232
70. Jones D.P., Miller L.A., Dowling C., Chesney R.W.: Regulation of taurine transporter activity in LLC-PK1 cells: Role of protein synthesis and protein kinase C activation. J. Am. Soc. Nephrol., 1991; 2: 1021-1029
71. Kanayama A., Inoue J., Sugita-Konishi Y., Shimizu M., Miyamoto Y.: Oxidation of IkB-A at methionine 45 is one cause of taurine chloramine-induced inhibition of NF-κB activation. J. Biol. Chem., 2002; 277: 24049-24056
72. Kang Y.S., Ohtsuki S., Takanaga H., Tomi M., Hosoya K., Terasaki T.: Regulation of taurine transport at the blood-brain barrier by tumor necrosis factor-alpha, taurine and hypertonicity. J. Neurochem., 2002; 83: 1188-1195
73. KEGG: Kyoto Encyclopedia of Genes and Genomes. http://www.genome.jp/kegg (05.02.2008)
74. Kim H.W., Lee A.J., You S, Park T., Lee D.H.: Characterization of taurine as inhibitor of sodium glucose transporter. Adv. Exp. Med. Biol., 2006; 583: 137-145
75. Kim S. L., Kim S.K., Park C.H. Introduction and nutritional evaluation of buckwheat sprouts as a new vegetable. Food Res. Int. 2004; 37:319-327
76. Kraus-Friedmann N., Feng L. The role of intracellular Ca2+ in the regulation of gluconeogenesis. Metabolism., 1996; 45: 389-403
77. Kuo Y.H., Rozen P., Lambein F., Frias J., Vidal-Valverde C.: Effects of different germination conditions on the contents of free protein and non-protein amino acids of commercial legumes. Food Chem., 2004; 86: 537-545
78. Kuriyama K.: Taurine as a neuromodulator. Fed. Proc., 1980; 39: 2680-2684
79. Kwon Y.H., Stipanuk M.H.: Cysteine regulates expression of cysteine dioxygenase and gamma-glutamylcysteine synthetase in cultured rat hepatocytes. Am. J. Physiol. Endocrinol. Metab., 2001; 280: 804-815
80. Lake N., Verdone-Smith C.: Immunocytochemical localization of taurine in the mammalian retina. Curr. Eye Res., 1989; 8: 163-173
81. Lima L. Matus P., Drujan B.: Taurine-induced regeneration of goldfish retina in culture may involved a calcium mediated mechanism. J. Neurochem., 1993; 60: 2153-2157
82. Lima L., Matus P., Drujan B.: The interaction of substrate and taurine modulates the putgrowth from regenerating goldfish retinal explants. Int. J. Dev. Neurosci., 1989; 7: 375-382
83. Liu Q.R., Lopez-Corcuera B., Nelson H., Mandiyan S., Nelson N.: Cloning and expression of a cDNA encoding the transporter of taurine and beta-alanine in mouse brain. Proc. Natl. Acad. Sci. USA, 1992; 89: 12145-12149
84. Lombardini J.B.: Quantitative analysis of the combination of doseeffects of taurine and taurine analogues on the phosphorylation of an 44 kD protein present in a mitochondrial subfraction of rat heart. J. Cardiovasc. Pharmacol., 1996; 28: 107-114
85. Lombardini J.B., Props C.: Effect of kinase inhibitors and taurine analogues on phosphorylation of specific proteins in mitocondrial fractions of rat heart and retina. Adv. Exp. Med. Biol., 1996; 403: 343-350
86. Lombardini J.B., Schaffer S.W., Azuma J.: Taurine: nutritional value and mechanisms of action. Proceedings of the Waltham Symposium on Taurine and Cat Nutrition and of the International Taurine Symposium. Orange Beach, Alabama, October 8-10, 1991. Adv. Exp. Med. Biol., 1992; 315: 1-441
87. Marcinkiewicz J., Grabowska A., Bereta J., Stelmaszynska T.: Taurine chloramine, a product of activated neutrophils, inhibits in vitro the generation of nitric oxide and other macrophage inflammatory mediators. J. Leukoc. Biol., 1995; 58: 667-674
88. Marcinkiewicz J., Nowak B., Grabowska A., Bobek M., Petrovska L., Chain B.: Regulation of murine dendritic cell functions in vitro by taurine chloramine, a major product of the neutrophil myeloperoxidasehalide system. Immunology, 1999; 98: 371-378
89. Maturo J., Kulakowski E.C.: Taurine binding to the purified insulin receptor. Biochem. Pharmacol., 1988; 37: 3755-3760
90. Matus P., Cubillos S., Lima L.: Differential effect of taurine and serotonin on the outgrowth from explants or isolated cells of the retina. Int. J. Dev. Neurosci., 1997; 15: 785-793
91. McCourt M., Wang J.H., Sookhai S., Redmond H.P.: Taurolidine inhibits tumor cell growth in vitro and in vivo. Ann. Surg. Oncol., 2000; 7: 685-691
92. Militante J., Lombardini J.B.: Age-related retinal degeneration in animal models of aging: possible involvement of taurine deficiency and oxidative stress. Neurochem. Res., 2004; 29: 151-160
93. Miyakawa H., Woo S.K., Dahl S.C., Handler J.S., Kwon H.M.: Tonicityresponsive enhancer binding protein, a rellike protein that stimulates transcription in response to hypertonicity. Proc. Natl. Acad. Sci. USA, 1999; 96: 2538-2542
94. Miyamoto Y., Marczin N., Catravas J.D., Del Monte, M.A.: Cholera toxin enhances taurine uptake in cultures of human retinal pigment epithelial cells. Curr. Eye Res., 1996; 15: 229-236
95. Mochizuki T., Satsu H., Shimizu M.: Tumor necrosis factor alpha stimulates taurine uptake and transporter gene expression in human intestinal Caco-2 cells. FEBS Lett., 2002; 517: 92-96
96. Mollerup J., Lambert I.H.: Phosphorylation is involved in the regulation of the taurine influx via the beta-system in Ehrlich ascites tumor cells. J. Membr. Biol., 1996; 150: 73-82
97. Movassat J., Portha B.: Beta-cell growth in the neonatal Goto-Kakisaki rat and regeneration after treatment with streptozotocin at birth. Diabetologia, 1999; 42: 1098-1106
98. Mozaffari M.S., Azuma J, Patel C, Schaffer S.W.: Renal excretory responses to saline load in the taurine-depleted and the taurine-supplemented rat. Biochem. Pharmacol., 1997; 54: 619-624
99. Nandhini A.T., Anuradha C.V.: Taurine modulates kallikrein activity and glucose metabolism in insulin resistant rats. Amino Acids, 2002; 22: 27-38
100. Nelson N.: The family of Na+/Cl-neurotransmitter transporters. J. Neurochem., 1998; 71: 1785-1803
101. Nishimura N., Umeda C., Oda H., Yokogoshi H.: The effect of taurine on the cholesterol metabolism in rats fed dietssupplemented with cholestyramine or high amounts of bile acid. J. Nutr. Sci. Vitaminol., 2003; 49: 21-26
102. Odetti P., Pesce C., Traverso N. Menini S., Maineri E.P., Cosso L., Velentini S., Patriarca S., Cottalasso D., Marinari U.M., Pronzato M.A.: Comparative trial of N-acetyl-cysteine, taurine, and oxerutin on skin and kidney damage in long-term experimental diabetes. Diabetes, 2002; 52: 499-505
103. Park E., Alberti J., Quinn M.R., Schuller-Levis G.: Taurine chloramine inhibits production of superoxide anion, IL-6 and IL-8 in activated human polymorphonuclear leukocytes. Adv. Exp. Med. Biol., 1998; 442: 177-182
104. Park E., Jia J., Quinn M.R., Schuller-Levis G.: Taurine chloramine inhibits lymphocyte proliferation and decreases cytokine production in activated human leukocytes. Clin. Immunol., 2002; 102: 179-184
105. Parsons R.B., Sampson D., Huggins C.C., Waring R.H., Williams A.C., Ramsden D.B.: Renal localisation of rat cysteine dioxygenase. Nephron, 2001; 88: 340-346
106. Parsons R.B., Waring R.H., Williams A.C., Ramsden D.B.: Cysteine dioxygenase: Regional localisation of protein and mRNA in rat brain. J. Neurosci. Res., 2001; 65: 78-84
107. Patel A., Rochelle J.M., Jones J.M., Sumegi G., Uhl G.R., Seldin M.F., Meisler M.H., Gregor P.: Mapping of the taurine transporter gene to mouse chromosome 6 and to the short arm of human chromosome 3. Genomics, 1995; 1: 314-317
108. Pierno S., Tricarico D., De Luca A., Campagna F., Carotti A., Casini G., Conte Camerino D.C.: Effects of taurine analogues on chloride channel conductance of rat skeletal muscle fibers: A structure-activity relationship investigation. Naunyn. Schmiedebergs Arch. Pharmacol., 1994; 349: 416-421
109. Qian X., Vinnakota S., Edwards C., Sarkar H.K.: Molecular characterization of taurine transport in bovine aortic endothelial cells. Biochim. Biophys. Acta, 2000; 1509: 324-334
110. Ramamoorthy S., Del Monte M.A., Leibach F.H., Ganapathy V.: Molecular identity and calmodulin-mediated regulation of the taurine transporter in a human retinal pigment epithelial cell line. Curr. Eye Res. 1994; 13: 523-529
111. Ramamoorthy S., Leibach F.H., Mahesh V.B., Han H., Yang-Feng T., Blakely R.D., Ganapathy V.: Functional characterization and chromosomal localization of a cloned taurine transporter from human placenta. Biochem. J., 1994; 300: 893-900
112. Ran J., Hirano T., Adachi M.: Angiotensin II type 1 receptor blocker ameliorates overproduction and accumulation of triglyceride in the liver of Zucker fatty rats. Am. J. Physiol. Endocrinol. Metab., 2004; 287: 227-232
113. Reymond I., Almarghini K., Tappaz M.: Immunocytochemical localization of cysteine sulfinate decarboxyalse in astrocytes in the cerebellum and hippocampus: A quantitatiave double immunofluorescence study with glial fibrillary acidic protein and S-100 protein. Neuroscience, 1996; 75: 619-633
114. Reymond I., Bitoun M., Levillain O., Tappaz M.: Regional expression and histological localization of cysteine sulfinate decarboxylase mRNA in the rat kidney. J. Histochem. Cytochem., 2000; 48: 1461-1468
115. Rozan P., Kuo Y.H., Lambein F.: Amino acids in seeds and seedlings of the genus Lens. Phytochemistry, 2001; 58: 281-289
116. Saransari P., Oja S.S.: Taurine and neural cell damage. Amino Acids, 2000; 19: 509-526
117. Satoh H., Sperelakis N.: Review of some actions of taurine on ion channels of cardiac muscle cells and others. Gen Pharmacol., 1998; 30: 451-463
118. Schaffer S., Takahashi K., Azuma J.: Role of osmoregulation in the action of taurine. Amino Acids, 2000; 19: 527-546
119. Schuller-Levis G.B., Gordon R.E., Wang C., Park E.: Taurine reduces lung inflammation and fibrosis caused by bleomycin. Adv. Exp. Med. Biol., 2003; 526: 395-402
120. Schuller-Levis G., Mehta P.D., Rudelli R., Sturman J.: Immunologic consequences of taurine deficiency in cats. J. Leukoc. Biol., 1990; 47: 321-331
121. Schuller-Levis G.B., Park E.: Taurine: new implications for an old amino acid. FEMS Microbiol. Lett., 2003; 226: 195-202
122. Schuller-Levis G.B., Park E.: Taurine and its chloramine: modulators of immunity. Neurochem. Res., 2004; 29: 117-126
123. Shimada M., Koide T., Kuroda E., Tsuboyama N., Hosokawa Y., Watanabe M.: Expression and localization of cysteine dioxygenase mRNA in the liver, lung, and kidney of the rat. Amino Acids, 1998; 15: 143-150
124. Smith K.E., Borden L.A., Wang C.H., Hartig P.R., Branchek T.A., Weinshank R.L.: Cloning and expression of a high affinity taurine transporter from rat brain. Mol. Pharmacol., 1992; 42: 563-569
125. Spitze A.R., Wong D.L., Rogers Q.R., Fascetti A.J.: Taurine concentration in animal feed ingredients: cooking influence taurine content. J. Anim. Physiol. Anim. Nutr., 2003; 87: 251-262
126. Stevens M.J., Hosaka Y., Masterson J.A., Jones S.M., Thomas T.P., Larkin D.D.: Downregulation of the human taurine transporter by glucose in cultured retinal pigment epithelial cells. Am. J. Physiol., 1999; 277: E760-E771
127. Stevens M.J., Lattimer S.A., Kamijo M., Van Huysen C., Sima A.A., Greene D.A.: Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat. Diabetologia, 1993; 36: 608-614
128. Stintzing F.C., Schieber Carle R.: Phytochemical and nutritional significance of cactus pear. Europ. Food Res. Technol., 2001; 212: 396-407
129. Stipanuk M.H.: Role of the liver in regulation of body cysteine and taurine levels: A brief review. Neurochem. Res., 2004; 29: 105-110
130. Stipanuk M.H., Londono M., Lee J.I., Hu M., Yu A.F.: Enzymes and metabolites of cysteine metabolism in nonhepatic tissues of rats show little response to changes in dietary protein or sulfur amino acid levels. J. Nutr., 2002; 132: 3369-3378
131. Sturman J.A.: Taurine in development. Physiol. Rev., 1993; 73: 119-147
132. Sumizu K.: Oxidation of hypotaurine in rat liver. Biochim. Biophys. Acta, 1962; 63: 210-212
133. Takenaka M., Preston A.S., Kwon H.M., Handler J.S.: The tonicity-sensitive element that mediates increased transcription of the betaine transporter gene in response to hypertonic stress. J. Biol. Chem., 1994; 269: 29379-29381
134. Tappaz M.L.: Taurine biosynthetic enzymes and taurine transporter: molecular identification and regulations. Neurochem. Res., 2004; 29: 83-96
135. Tchoumkeu-Nzouessa G.C., Rebel G.: Regulation of taurine transport in rat astrocytes by protein kinase C: Role of calcium and calmodulin. Am. J. Physiol., 1996; 270: C1022-C1028
136. Tchoumkeu-Nzouessa G.C., Rebel G.: Characterization of taurine transport in human glioma GL15 cell line: Regulation by protein kinase C. Neuropharmacology, 1996; 35: 37-44
137. Tomei S., Torimoto M., Hayashi Y., Inoue K., Yuasa H., Watanabe J.: Kinetic characterization of carrier-mediated transport systems for D-glucose and taurocholate in the everted sacs of colon. Biol. Pharm. Bull., 2003; 26: 899-901
138. Tonge D.A., Golding J.P., Gordon-Weeks P.R.: Expression of a developmentally regulated, phosphorylated isoform of microtubuleassociated protein 1B in sprouting and regenerating axons in vitro. Neuroscience, 1996; 73: 541-551
139. Tsuboyama N., Hosokawa Y., Totani M., Oka J., Matsumoto A., Koide T., Kodama H.: Structural organization and tissue-specific expression of the gene encoding rat cysteine dioxygenase. Gene, 1996; 181: 161-165
140. Tsuboyama-Kasaoka N., Hosokawa Y., Kodama H., Matsumoto A., Oka J., Totani, M.: Human cysteine dioxygenase gene: Structural organization, tissue-specific expression and downregulation by phorbol 12-myristate 13-acetate. Biosci. Biotechnol. Biochem., 1999; 63: 1017-1024
141. Uchida S., Kwon H.M., Yamauchi A., Preston A.S., Marumo F., Handler J.S.: Molecular cloning of the cDNA for an MDCK cell Na+ and Cl-dependent taurine transporter that is regulated by hypertonicity. Proc. Natl. Acad. Sci. USA, 1992; 89: 8230-8234
142. van Gelder N.M.: Rectification of abnormal glutamic acid levels by taurine. W: Taurine, red.: Huxtable R. i Barbeau A. Raven Press, New York, 1976, 293-302
143. van Gelder N.M., Bèlanger F.: Development of the amino acid pools in chick embryo brain, heart, and eye: taurine, valine, glutamine, and phosphoethanolamine. J. Neurosci. Res., 1988; 19: 110-118
144. Vinnakota S., Qian X., Egal H., Sarthy V., Sarkar H.K.: Molecular characterization and in situ localization of a mouse retinal taurine transporter. J. Neurochem., 1997; 69: 2238-2250
145. Warskulat U., Borsch E., Reinehr R., Heller-Stilb B., Roth C., Witt M., Häussinger D.: Taurine deficiency and apoptosis: findings from the taurine transporter knockout mouse. Arch. Biochem. Biophys., 2007; 462: 202-209
146. Watson R.W., Redmond H.P., Mc Carthy J., Bouchier-Hayes D.: Taurolidine, an antilipopolysaccharide agent, has immunoregulatory properties that are mediated by the amino acid taurine. J. Leukoc. Biol., 1995; 58: 299-306
147. Weiss S.J., Klein R., Slivka A., Wei M.: Chlorination of taurine by human neutrophils: Evidence for hypochlorous acid generation. J. Clin. Invest., 1982; 70: 598-607
148. Wu G., Knabe D.A.: Free and protein-bound amino acids in sow's colostrum and milk. J. Nutr., 1994; 124: 415-424
149. Wu J.Y., Chen W.Q., Tang X.W., Jin H., Foos T., Schloss J.V., Davis K.M., Faiman M.D., Hsu, C.C.: Mode of action of taurine and regulation dynamics of its synthesis in the CNS. W: Taurine and Excitable Tissues, red.: Della-Corte L., Huxtable R.J., Plenum Press, 2000, 35-44
150. Wu J.Y., Jin H., Schloss J.V., Faiman M.D., Ningaraj S.N., Foos T., Chen W.: Neurotoxic effect of acamprosate, n-acetyl-homotaurine, in cultured neurons. J. Biomed. Sci., 2001; 8: 96-103